LYP3, a New Bestatin Derivative for Aminopeptidase N Inhibition

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|7|1|32-36

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.7, Iss.1, 2011-01, pp. : 32-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Synthesis and Activity Evaluation of a Bestatin Derivative (LYP) as an Aminopeptidase N Inhibitor

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 6, 2009-09 ,pp. : 420-423

Bentham Science Publishers

Access to resources Recommend Favorite

LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin

By Gao Jian-Jun  

Investigational New Drugs, Vol. 29, Iss. 4, 2011-08 ,pp. : 574-582

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of aminopeptidase N should be investigated as a strategy for the prevention and treatment of SARS

By  

Inpharma, Vol. 1, Iss. 1386, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Aminopeptidase A inhibitors: new hype for hypertension?

By  

Inpharma, Vol. 1, Iss. 1640, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Advances in Bacterial Methionine Aminopeptidase Inhibition

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 4, 2016-02 ,pp. : 397-18

Bentham Science Publishers

Access to resources Recommend Favorite